ZYSTRENVA Trademark

Trademark Overview

On Friday, August 8, 2014, a trademark application was filed for ZYSTRENVA with the United States Patent and Trademark Office. The USPTO has given the ZYSTRENVA trademark a serial number of 86361017. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 9, 2018. This trademark is owned by Merck Sharp & Dohme Corp.. The ZYSTRENVA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, antivirals
zystrenva

General Information

Serial Number86361017
Word MarkZYSTRENVA
Filing DateFriday, August 8, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 9, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 6, 2015

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, antivirals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, April 9, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 9, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 8, 2017EXTENSION 5 GRANTED
Monday, August 7, 2017EXTENSION 5 FILED
Monday, August 7, 2017TEAS EXTENSION RECEIVED
Monday, August 7, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 21, 2017EXTENSION 4 GRANTED
Tuesday, February 21, 2017EXTENSION 4 FILED
Tuesday, February 21, 2017TEAS EXTENSION RECEIVED
Wednesday, September 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 13, 2016EXTENSION 3 GRANTED
Wednesday, August 24, 2016EXTENSION 3 FILED
Wednesday, August 24, 2016TEAS EXTENSION RECEIVED
Thursday, March 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 16, 2016EXTENSION 2 GRANTED
Monday, February 15, 2016EXTENSION 2 FILED
Monday, February 15, 2016TEAS EXTENSION RECEIVED
Wednesday, September 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2015EXTENSION 1 GRANTED
Wednesday, August 19, 2015EXTENSION 1 FILED
Monday, August 31, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 19, 2015TEAS EXTENSION RECEIVED
Tuesday, March 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 6, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 24, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 24, 2014ASSIGNED TO EXAMINER
Tuesday, August 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 12, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

zystrenva antivirals namely preparations pharmaceutical